Research stories

Insights from the world of metabolomics and the future of health.

All

What are clinically validated biomarkers and how they make research data robust

October 8, 2020

Using Metabolomics in COVID-19 research: COVIDIME study 

August 24, 2020

How urine analysis is changing diabetes research

Tackling type 1 diabetes complications with early detection: the FinnDiane Study

NMR or MS – which technology to pick when analysing biofluids?

August 26, 2019

How metabolomics can help in understanding the host-gut microbe interactions: Jingyuan Fu

August 14, 2019

The potential of using blood and urine samples in gut health research

Mini-Review: Advanced lipoprotein profiling

Data visualization tool for R-users

Emmi Tikkanen on how biobank data is helping us to understand cardiovascular disease risk

November 4, 2018

Research highlight: Using metabolomics to compare PCSK9 and statins

August 21, 2018

Research highlight: Uncovering the relationship between diet and CVD risk

Research highlight: Investigating the metabolomics of menopause

The scientific opportunities are endless - UK Biobank Scientific Conference 2018

Research highlight: Unravelling the role of branched chain amino acids in dementia and Alzheimer’s disease

Research highlight: Uncovering the relationship between amino acids and type 2 diabetes complications

Research highlight: Examining the metabolic effects of non-alcoholic fatty liver disease (NAFLD)

For individuals

Blood test and app

For business

Nightingale for business

Health initiatives

For investors

Nightingale as an investment

Financial information

Share and shareholders

Investor relations

For research

Blood Biomarker Analysis

About us

Get our newsletter

Interested in getting the latest news about Nightingale? Subscribe to our newsletter.

Nightingale Health Oyj

Mannerheimintie 164a, 00300 Helsinki, Finland

© 2020 Nightingale HealthTerms and policies